The U.S. pharmaceutical industry seeks to alter Medicare drug price negotiation laws under Trump's return. China approves ...

Sarah Sammons, MD, discusses some of the challenges seen with different regimens for HER2-positive metastatic breast cancer ...

China: Enhertu, a blockbuster breast cancer drug of AstraZeneca, will be included in China's state-run health insurance ...

Discover the latest insights and trends in personal finance with this comprehensive article written by a financial expert.

The latest health news includes studies on medications for thyroid issues and breast cancer, the healthcare industry's ...